Warhound
Warhound develops working dogs for military, law-enforcement and emergency-response teams.
$200MSeed
ParticipantBC
Breyer Capital
Activity from announced rounds
Activity in this selectionUnited States · Oct 23, 2026 · Sep 24, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $335M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionSoufflé Therapeutics
Soufflé Therapeutics develops targeted RNA medicines for patients with muscle disorders and heart failure.
$135MSeries B
Participant